EKF Diagnostics (LON:EKF) Shares Up 0.4% – Here’s What Happened

Shares of EKF Diagnostics Holdings plc (LON:EKF) were up 0.4% during trading on Wednesday. The stock traded as high as GBX 24.64 and last traded at GBX 24.50. 108,105 shares traded hands during trading, a decline of 69% from the average session volume of 343,814 shares. The stock had previously closed at GBX 24.40.

EKF Diagnostics Stock Performance

The company has a market cap of £104.85 million, a PE ratio of 42.24 and a beta of 0.51. The business’s 50-day moving average is GBX 24.78 and its 200 day moving average is GBX 25.33. The company has a debt-to-equity ratio of 2.09, a quick ratio of 1.77 and a current ratio of 4.72.

EKF Diagnostics (LON:EKF) last posted its quarterly earnings results on Tuesday, September 15th. The company reported GBX 0.54 earnings per share (EPS) for the quarter. EKF Diagnostics had a net margin of 4.86% and a return on equity of 3.58%. On average, equities research analysts predict that EKF Diagnostics Holdings plc will post 2.30 EPS for the current fiscal year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.